首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Mediator probe PCR: A novel approach for detection of real-time PCR based on label-free primary probes and standardized secondary universal fluorogenic reporters
【24h】

Mediator probe PCR: A novel approach for detection of real-time PCR based on label-free primary probes and standardized secondary universal fluorogenic reporters

机译:介体探针PCR:一种基于无标记初级探针和标准化二级通用荧光报告基因的实时PCR检测新方法

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The majority of established techniques for monitoring real-time PCR amplification involve individual target-specific fluorogenic probes. For analysis of numerous different targets the synthesis of these probes contributes to the overall cost during assay development. Sequence-dependent universal detection techniques overcome this drawback but are prone to detection of unspecific amplification products. We developed the mediator probe PCR as a solution to these problems. METHODS: A set of label-free sequence-specific primary probes (mediator probes), each comprising a targetspecific region and a standardized mediator tag, is cleaved upon annealing to its target sequence by the polymerases' 5' nuclease activity. Release of a mediator triggers signal generation by cleavage of a complementary fluorogenic reporter probe. RESULTS: Real-time PCR amplification of human papillomavirus 18(HPV18), Staphylococcus aureus, Escherichia coli, and Homo sapiens DNA dilution series showed exceptional linearity when detected either by novel mediator probes (r 2 = 0.991-0.999) or state-ofthe-art hydrolysis probes (TaqMan probes) (r 2 = 0.975-0.993). For amplification of HPV18 DNA the limits of detection were 78.3 and 85.1 copies per 10-μL reaction when analyzed with the mediator probe and hydrolysis probe, respectively. Duplex amplification of HPV18 target DNA and internal standard had no effects on back calculation of target copy numbers when quantified with either the mediator probe PCR (r 2 = 0.998) or the hydrolysis probe PCR (r 2 = 0.988). CONCLUSIONS: The mediator probe PCR has equal performance to hydrolysis probe PCR and has reduced costs because of the use of universal fluorogenic reporters.
机译:背景:大多数用于监测实时PCR扩增的既定技术涉及单个靶标特异性荧光探针。为了分析许多不同的靶标,这些探针的合成会增加分析开发过程中的总成本。依赖序列的通用检测技术克服了这一缺点,但易于检测非特异性扩增产物。我们开发了介体探针PCR作为解决这些问题的方法。方法:一组无标记的序列特异性初级探针(介体探针),每个探针均包含靶标特异性区域和标准化的介体标签,通过聚合酶的5'核酸酶活性在退火至其靶序列后被裂解。介体的释放通过切割互补的荧光报告基因探针触发信号产生。结果:人新型乳头瘤病毒18(HPV18),金黄色葡萄球菌,大肠杆菌和智人DNA稀释系列的实时PCR扩增在通过新型介体探针(r 2 = 0.991-0.999)或状态检测时显示出优异的线性现有技术的水解探针(TaqMan探针)(r 2 = 0.975-0.993)。对于HPV18 DNA的扩增,当使用介体探针和水解探针进行分析时,检测限分别为每10μL反应78.3和85.1拷贝。当用介体探针PCR(r 2 = 0.998)或水解探针PCR(r 2 = 0.988)定量时,HPV18目标DNA和内标的双重扩增对目标拷贝数的反算没有影响。结论:介体探针PCR与水解探针PCR具有相同的性能,并且由于使用了通用的荧光报告基因而降低了成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号